Allspring Global Investments Holdings, LLC Amicus Therapeutics, Inc. Transaction History
Allspring Global Investments Holdings, LLC
- $62.1 Billion
- Q3 2024
A detailed history of Allspring Global Investments Holdings, LLC transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Allspring Global Investments Holdings, LLC holds 16,063 shares of FOLD stock, worth $158,541. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,063
Previous 17,099
6.06%
Holding current value
$158,541
Previous $169,000
1.18%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding FOLD
# of Institutions
313Shares Held
314MCall Options Held
516KPut Options Held
833K-
Vanguard Group Inc Valley Forge, PA28.8MShares$284 Million0.01% of portfolio
-
Perceptive Advisors LLC New York, NY28.1MShares$277 Million7.83% of portfolio
-
Black Rock Inc. New York, NY24.4MShares$241 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA24MShares$237 Million0.05% of portfolio
-
Avoro Capital Advisors LLC New York, NY23.2MShares$229 Million3.72% of portfolio
About AMICUS THERAPEUTICS, INC.
- Ticker FOLD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 280,497,984
- Market Cap $2.77B
- Description
- Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...